Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha B Hunter

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|April 18, 2016
Personalized Immune Therapy: A Slippery Fish?Natasha B Hunter, Charles G Drake
Oncology (Williston Park, N.Y.)|January 4, 2018
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing OutcomesNatasha B Hunter, Samantha Vogt, Richard F Ambinder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical UtilityNatasha B Hunter, Mark R Kilgore, Nancy E Davidson
Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual DiseaseNatasha B Hunter, Heather A Parsons, Leslie Cope, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|April 18, 2016
Personalized Immune Therapy: A Slippery Fish?Natasha B Hunter, Charles G Drake
Oncology (Williston Park, N.Y.)|January 4, 2018
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing OutcomesNatasha B Hunter, Samantha Vogt, Richard F Ambinder
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical UtilityNatasha B Hunter, Mark R Kilgore, Nancy E Davidson
Breast Cancer Research : BCR|February 18, 2025
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancerNatasha B Hunter, Lanell M Peterson, Jennifer M Specht, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual DiseaseNatasha B Hunter, Heather A Parsons, Leslie Cope, et al.
Pageof 1